NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Genre Technical Report ✖Remove constraint Genre: Technical Report Copyright Public domain ✖Remove constraint Copyright: Public domain

301. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, December 2017
Subject(s):
Communication
Drug Industry
Investigational New Drug Application
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

302. Unique device identification: policy regarding compliance dates for class I and unclassified devices : immediately in effect guidance for industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, January 16, 2018
Subject(s):
Equipment and Supplies -- classification
Product Labeling -- standards
Product Packaging -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

303. Compounded drug products that are essentially copies of a commercially available drug product under Section 503A of the Federal Food, Drug, and Cosmetic Act

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, January 2018
Subject(s):
Drug Compounding -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

306. Requirements for transactions with first responders under section 582 of the Federal Food, Drug, and Cosmetic Act--compliance policy

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, February 2017
Subject(s):
Emergency Medical Services -- legislation & jurisprudence
Emergency Responders -- legislation & jurisprudence
Pharmaceutical Preparations -- supply & distribution
Drug Therapy
Legislation, Drug
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

307. Providing regulatory submissions in electronic format--certain human pharmaceutical product applications and related submissions using the eCTD specifications

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2017
Subject(s):
Automatic Data Processing -- standards
Investigational New Drug Application
Drug Approval -- legislation & jurisprudence
Drug Approval -- organization & administration
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

308. Community-based long-term care: Wisconsin stays ahead : site visit report

Publication:
Washington, D.C. : George Washington University, 2007
Subject(s):
Community Health Services -- organization & administration
Delivery of Health Care -- organization & administration
Home Care Services -- organization & administration
Long-Term Care -- organization & administration
Aged
Caregivers
Chronic Disease
Disabled Persons
Family
Medicaid
Medical Informatics
Medicare
Mental Health Services
Rural Health Services
Humans
United States
Wisconsin

309. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Dietary Supplements
Drug and Narcotic Control
Government Regulation
Marketing of Health Services
Memory -- drug effects
Memory Disorders -- drug therapy
Advertising as Topic
Commerce
Internet
Humans
United States
United States. Federal Trade Commission.
United States. Food and Drug Administration.

311. Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Drugs, Generic -- economics
Drugs, Investigational -- economics
Investigational New Drug Application -- economics
Drug Approval -- economics
Humans
United States
United States. Food and Drug Administration.

312. Physician workforce: locations and types of graduate training were largely unchanged, and federal efforts may not be sufficient to meet needs : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Education, Medical, Graduate -- statistics & numerical data
Health Manpower
Physicians, Family -- education
Physicians, Family -- supply & distribution
Primary Health Care -- manpower
Education, Medical, Graduate -- trends
Forecasting
Medicine -- statistics & numerical data
Nurse Practitioners -- supply & distribution
Physician Assistants -- supply & distribution
Rural Health Services -- manpower
Urban Health Services -- manpower
Humans
United States
United States. Department of Health and Human Services.

313. VA information technology: pharmacy system needs additional capabilities for viewing, exchanging, and using data to better serve veterans : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Clinical Pharmacy Information Systems
Health Information Interoperability
Veterans Health
Veterans
Humans
United States
United States. Department of Defense.
United States. Department of Veterans Affairs.
United States. Veterans Health Administration.

314. Veterans Affairs: improved management processes are necessary for it systems that better support health care : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Medical Informatics -- organization & administration
Veterans Health
Community Health Services
Health Services Accessibility
Health Services Needs and Demand
Insurance, Pharmaceutical Services
Humans
United States
United States. Veterans Health Administration

315. Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Economics, Hospital
Quality of Health Care
Reimbursement, Incentive
Value-Based Purchasing
Hospitals, Rural -- economics
Hospitals, Urban -- economics
Safety-net Providers -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

316. Gulf War illness: improvements needed for VA to better understand, process, and communicate decisions on claims : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Disability Evaluation
Persian Gulf Syndrome
Veterans
Veterans Disability Claims
Veterans Health
Insurance Claim Review
Humans
United States
United States. Department of Veterans Affairs.

318. Medicaid expansion: behavioral health treatment use in selected states in 2014 : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Medicaid
Mental Disorders -- drug therapy
Mental Disorders -- therapy
Mental Health Services -- utilization
Analgesics, Opioid -- therapeutic use
Forecasting
Mental Health Services -- trends
Opioid-Related Disorders
Humans
Iowa
New York
Washington
West Virginia
United States
United States.

319. Investigational new drugs: FDA has taken steps to improve the expanded access program but should further clarify how adverse events data are used : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Adverse Drug Reaction Reporting Systems
Drugs, Investigational -- adverse effects
Drugs, Investigational -- therapeutic use
Drug Approval
Health Services Accessibility
Humans
United States
United States. Food and Drug Administration.

320. Early learning and child care: agencies have helped address fragmentation and overlap through improved coordination : report to the Chairwoman, Committee on Education and the Workforce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Early Intervention (Education) -- economics
Early Intervention (Education) -- organization & administration
Education, Special
Child Development
Child, Preschool
Disabled Children -- education
Financing, Government
Government Programs
Schools, Nursery
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Labor.
United States. Department of the Interior.

321. Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Cost Sharing -- economics
Government Regulation
Health Insurance Exchanges -- economics
Income Tax
Eligibility Determination
Insurance, Health -- economics
Humans
United States
United States. Internal Revenue Service.
United States.
Centers for Medicare & Medicaid Services (U.S.)

323. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Air Ambulances -- economics
Fees and Charges
Insurance Coverage -- economics
Cost Sharing
Data Collection
Disclosure
Government Regulation
Humans
United States
United States. Department of Transportation.
Centers for Medicare & Medicaid Services (U.S.)

324. Medicare: CMS should evaluate providing coverage for disposable medical devices that could substitute for durable medical equipment : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Durable Medical Equipment -- economics
Equipment Reuse -- economics
Insurance Coverage -- economics
Insurance, Health, Reimbursement
Medicare -- economics
Blood Glucose Self-Monitoring -- instrumentation
Continuous Positive Airway Pressure -- instrumentation
Cost Savings
Infusion Pumps -- economics
Negative-Pressure Wound Therapy -- instrumentation
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

325. VA real property: planning and communication improvements could help better align facilities with veterans' needs : testimony before the Committee on Veterans' Affairs, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 12, 2017
Subject(s):
Health Facility Planning
Hospitals, Veterans -- organization & administration
Health Services Accessibility
Health Services Needs and Demand
Veterans Health
Humans
United States
United States. Department of Veterans Affairs.

326. Early learning and child care: overview of federal investment and agency coordination : testimony before the Subcommittee on Early Childhood, Elementary, and Secondary Education, Committee on Education and the Workforce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 13, 2017
Subject(s):
Child Care
Child Development
Early Intervention (Education)
Interinstitutional Relations
Child, Preschool
Federal Government
Financing, Government
Infant
Humans
United States
United States. Department of Education.
United States. Department of Health and Human Services.
United States. Department of the Interior.

327. Gulf War illness: additional actions needed to improve VA's claims process : testimony before the Subcommittees on Oversight and Investigations and Disability Assistance and Memorial Affairs, Committee on Veterans' Affairs, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 13, 2017
Subject(s):
Disability Evaluation
Insurance Claim Review
Persian Gulf Syndrome
Veterans Disability Claims
Veterans Health
Humans
United States
United States. Department of Veterans Affairs.

328. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 18, 2017
Subject(s):
Government Regulation
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Contract Services
Economics, Pharmaceutical
Forecasting
Government Programs -- statistics & numerical data
Insurance, Health, Reimbursement
Pharmacies -- statistics & numerical data
Pharmacies -- trends
Humans
United States
United States. Health Resources and Services Administration.

329. VA health care: improvements needed in data and monitoring of clinical productivity and efficiency : testimony before the Subcommittee on Health, Committee on Veterans Affairs, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 13, 2017
Subject(s):
Delivery of Health Care -- organization & administration
Efficiency, Organizational
Hospitals, Veterans -- organization & administration
Veterans Health
Data Collection
Health Expenditures
Humans
United States
United States. Department of Veterans Affairs.

330. Medicare Advantage program integrity: CMS's efforts to ensure proper payments and identify and recover improper payments : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 19, 2017
Subject(s):
Financial Audit
Fraud -- prevention & control
Insurance, Health, Reimbursement
Medicare Part C -- economics
Fee-for-Service Plans -- economics
Insurance Claim Review
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

331. Telehealth: use in Medicare and Medicaid : testimony before the Subcommittee on Agriculture, Energy, and Trade and Subcommittee on Health and Technology, Committee on Small Business, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 20, 2017
Subject(s):
Insurance Coverage
Insurance, Health, Reimbursement
Medicaid -- economics
Medicare -- economics
Telemedicine -- economics
Telemedicine -- utilization
Health Services Accessibility
Reimbursement Mechanisms
Rural Health Services
Rural Population
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

332. Drug control policy: information on status of federal efforts and key issues for preventing illicit drug use : testimony before the Committee on Oversight and Government Reform, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 26, 2017
Subject(s):
Drug and Narcotic Control -- economics
Street Drugs -- adverse effects
Substance-Related Disorders -- mortality
Substance-Related Disorders -- prevention & control
Drug and Narcotic Control -- trends
Federal Government
Forecasting
Health Policy
Street Drugs -- supply & distribution
Humans
United States
United States. Office of National Drug Control Policy.
United States. Substance Abuse and Mental Health Services Administration.

333. SSA's Compassionate Allowance Initiative: improvements needed to make expedited processing of disability claims more consistent and accurate : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, August 2017
Subject(s):
Disability Evaluation
Eligibility Determination
Insurance Claim Review
Social Security
Humans
United States
United States. Social Security Administration.

334. Medicaid: states fund services for adults in institutions for mental disease using a variety of strategies : report to the Co-Chair, Caucus on International Narcotics Control, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, August 2017
Subject(s):
Insurance Coverage -- economics
Mental Disorders -- therapy
Mental Health Services -- economics
Residential Treatment -- economics
Residential Treatment -- statistics & numerical data
Substance-Related Disorders -- therapy
Adult
Health Services Accessibility
Managed Care Programs
Medicaid -- economics
Middle Aged
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

335. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, August 2017
Subject(s):
Government Regulation
Health Insurance Exchanges -- organization & administration
Medical Informatics -- organization & administration
Federal Government
Financing, Government
State Government
Humans
Hawaii
Minnesota
New York
Oregon
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

336. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, August 2017
Subject(s):
Community Health Services
Home Care Services
Long-Term Care
Managed Care Programs
Medicaid
Federal Government
Government Regulation
Health Services Accessibility
Quality Assurance, Health Care
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

337. Medicare: CMS Fraud Prevention System uses claims analysis to address fraud : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, August 2017
Subject(s):
Fraud -- prevention & control
Insurance Claim Review
Medicare
Public-Private Sector Partnerships
Contract Services
Data Interpretation, Statistical
Information Dissemination
Insurance, Health, Reimbursement
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

338. VA health care: opportunities exist for improving implementation and oversight of enrollment processes for veterans : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, Center for Science, Technology, Engineering, Health Care September 2017
Subject(s):
Veterans Health
Delivery of Health Care -- organization & administration
Health Services Accessibility
Insurance, Health
Government Regulation
Time Factors
Humans
United States
United States. Department of Veterans Affairs
United States. Veterans Health Administration.

339. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Age Factors
Health Benefit Plans, Employee -- economics
Sex Factors
Taxes -- legislation & jurisprudence
Blue Cross Blue Shield Insurance Plans -- economics
Government Employees
Health Care Costs
Humans
United States
United States. Internal Revenue Service.
United States.

340. Public health information technology: HHS has made little progress toward implementing enhanced situational awareness network capabilities : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Awareness
Communications Media
Information Dissemination -- methods
Public Health Administration
Disease Outbreaks
Information Technology
Interinstitutional Relations
Humans
United States
United States. Department of Health and Human Services.

341. Centers For Disease Control and Prevention: use of special interest projects to fund prevention research centers : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Preventive Health Services -- economics
Public Health
Research -- economics
Academic Medical Centers -- economics
Community-Institutional Relations
Financing, Government
Humans
United States
Centers for Disease Control and Prevention (U.S.)

342. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Cost Sharing -- economics
Eligibility Determination
Health Insurance Exchanges
Insurance, Health -- economics
Fraud
Income Tax
Humans
Idaho
Maryland
Rhode Island
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

344. VA health care quality: VA should improve the information it publicly reports on the quality of care at its medical facilities : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Hospitals, Veterans
Quality Indicators, Health Care
Quality of Health Care
Internet
Veterans Health
Humans
United States
United States. Department of Veterans Affairs.

345. Personal firearms: programs that promote safe storage and research on their effectiveness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Firearms
Patient Education as Topic
Safety
Wounds, Gunshot -- epidemiology
Wounds, Gunshot -- mortality
Wounds, Gunshot -- prevention & control
Adolescent
Child
Community Networks
Consumer Product Safety
Counseling
Forecasting
Suicide -- prevention & control
Suicide -- statistics & numerical data
Suicide -- trends
Humans
United States
United States. Department of Health and Human Services.

346. SSA's Compassionate Allowance initiative: actions needed to improve the accuracy and consistency of expedited processing of disability claims : testimony before the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 6, 2017
Subject(s):
Disability Evaluation
Eligibility Determination
Insurance Claim Review
Insurance, Disability
Social Security
Humans
United States
United States. Social Security Administration.

347. Human trafficking: investigations in Indian country or involving Native Americans and actions needed to better report on victims served : testimony before the Committee on Indian Affairs, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 27, 2017
Subject(s):
Human Trafficking -- prevention & control
Human Trafficking -- statistics & numerical data
Indians, North American
Data Collection
Federal Government
Human Trafficking -- legislation & jurisprudence
Law Enforcement
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Department of Justice.
United States. Department of the Interior.

348. Newborn health: federal action needed to address neonatal abstinence syndrome : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Neonatal Abstinence Syndrome -- economics
Neonatal Abstinence Syndrome -- therapy
Infant, Newborn
Insurance Coverage -- economics
Medicaid -- economics
Mothers
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders
Patient Education as Topic
Pregnancy
Prenatal Care
Social Stigma
Substance-Related Disorders -- therapy
Humans
United States
United States. Department of Health and Human Services.

349. Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Bioterrorism -- prevention & control
Civil Defense
Awareness
Biological Warfare
Data Collection
Information Dissemination
Public Health
Research
Humans
United States
United States. Department of Agriculture.
United States. Department of Defense.
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Environmental Protection Agency.

350. Drinking water: DOD has acted on some emerging contaminants but should improve internal reporting on regulatory compliance : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Drinking Water
Military Facilities
Perchlorates
Public Health
Water Pollutants, Chemical
Water Pollution, Chemical
Fires -- prevention & control
Groundwater
Water Supply
Humans
United States
United States. Department of Defense.
United States. Environmental Protection Agency.

351. Veterans Health Administration: better data and evaluation could help improve physician staffing, recruitment, and retention strategies : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Health Manpower
Personnel Selection
Personnel Turnover
Physician Incentive Plans
Physicians -- supply & distribution
Veterans Health
Data Collection
Staff Development
Humans
United States
United States. Veterans Health Administration.

352. Investigational new drugs: FDA's expanded access program : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 3, 2017
Subject(s):
Drug Approval -- statistics & numerical data
Drugs, Investigational -- therapeutic use
Health Services Accessibility
Patient Safety
Investigational New Drug Application
Humans
United States
United States. Food and Drug Administration.

353. FirstNet: efforts to establish the public-safety broadband network : testimony before the Subcommittee on Emergency Preparedness, Response, and Communications, Committee on Homeland Security, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 12, 2017
Subject(s):
Communication
Emergencies
Radio
Contract Services -- economics
Emergency Responders
Safety
Humans
United States
United States. Department of Homeland Security.
United States. Federal Communications Commission.

354. Part D plans generally include drugs commonly used by dual eligibles: 2017

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- statistics & numerical data
Drug Utilization
Medicare Part D -- economics
Humans
United States
United States. Department of Health and Human Services.
United States.

356. Financial analysis 2020: Volume three, Rehabilitation, psychiatric, long-term acute care, specialty : an annual report on the financial health of Pennsylvania non-GAC hospitals

Publication:
Harrisburg, PA : Pennsylvania Health Care Cost Containment Council, December 2021
Subject(s):
Economics, Hospital -- statistics & numerical data
Hospitals, Psychiatric -- economics
Hospitals, Rehabilitation -- economics
Hospitals, Special -- economics
Pennsylvania
United States

357. Financial analysis 2020: Volume two, Ambulatory surgery centers : an annual report on the financial health of Pennsylvania ambulatory surgery centers

Publication:
Harrisburg, PA : Pennsylvania Health Care Cost Containment Council, November 2021
Subject(s):
Ambulatory Care Facilities -- economics
Ambulatory Care Facilities -- statistics & numerical data
Surgicenters -- economics
Surgicenters -- statistics & numerical data
Pennsylvania
United States

362. Three-year hospitalization trends: opioids, alcohol, cocaine and amphetamines

Publication:
[Harrisburg, PA] : Pennsylvania Health Care Cost Containment Council, October 2020
Subject(s):
Alcohol-Related Disorders
Amphetamine-Related Disorders -- epidemiology
Cocaine-Related Disorders -- epidemiology
Drug Overdose -- epidemiology
Hospitalization -- trends
Opiate Overdose -- epidemiology
Opioid-Related Disorders -- epidemiology
Pennsylvania
United States

378. Report of the Commission appointed by the Sanitary Board of the City Councils, to visit Canada for the investigation of the epidemic cholera, prevailing in Montreal and Quebec

Author(s):
Philadelphia (Pa.). Sanitary Board. Commission Appointed to Visit Canada for the Investigation of the Epidemic Cholera Prevailing in Montreal and Quebec.
Publication:
Philadelphia : Mifflin & Parry, 1832
Subject(s):
Cholera -- epidemiology
Quebec

Refine by:

more »

more »

more »

more »

Current results range from 1803 to 2024